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Abstract 
The crystal structure of the cytochrome bcl complex (ubiquinol-cytochrome c reductase) from bovine heart sub- 
mitochondria was determined at 2.9 ~ resolution. The bcl complex in crystal exists as a closely interacting dimer, 
suggesting that the dimer is a functional unit. Over half of the mass of the complex, including subunits core 1 and core 2, 
are on the matrix side of the membrane, while most of the cytochrome b subunit is located within the membrane. There are 
13 transmembrane h lices in each monomer, eight of them belonging to cytochrome b. Two large cavities are made of the 
transmembrane h lices D, C, F and H in one monomer and helices D' and E' from the other monomer of cytochrome b, and 
the transmembrane h lices of cl, iron-sulfur protein (ISP), and subunits 10 and 11. These cavities provide entrances for 
ubiquinone or inhibitor and connect he Qi pocket of one monomer and the Qo pocket of the other monomer. Ubiquinol 
made at the Q~ site of one monomer can proceed to the nearby Qo site of the other monomer without having to leave the bcl 
complex. The soluble parts of cytochrome cl and ISE including their redox prosthetic groups, are located on the 
cytoplasmic side of the membrane. The distances between the four redox centers in the complex have been determined, and 
the binding sites for several electron transfer inhibitors have been located. Structural analysis of the protein/inhibitor 
complexes revealed that the extramembrane domain of the Rieske iron-sulfur protein may undergo substantial movement 
during the catalytic ycle of the complex. The Rieske protein movement and the larger than expected istance between FeS 
and cytochrome c 1 heme suggest that electron transfer reaction between FeS and cytochrome c 1 may involve movements or 
conformational changes in the soluble domain of iron-sulfur protein. The inhibitory function of E-13-methoxyacrylate- 
stilbene and myxothiazol may result from the increase of mobility in ISP, whereas the function of stigmatellin and 
5-undecyl-6-hydroxy-4,7-dioxobenzothiazole m y result from the immobilization of ISE © 1998 Elsevier Science B.V. 
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1. Introduction 
The cytochrome bcl complex (commonly known 
as ubiquinol-cytochrome c reductase or Complex III) 
is a segment of the mitochondrial respiratory chain 
*Corresponding author: Fax: 405 744 7799. 
that catalyzes antimycin-sensitive electron transfer 
from ubiquinol to cytochrome c [18,10]. The reaction 
is coupled to the translocation of protons across the 
mitochondrial inner membrane to generate a proton 
gradient and membrane potential for ATP synthesis. 
The purified cytochrome bcl complex contains 
eleven protein subunits with known amino acid 
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sequences. The complex consists of 2165 amino acid 
residues and four prosthetic groups, with a total 
molecular mass of 248 kDa without counting the 
bound phospholipids. The essential redox compo- 
nents of the cytochromes bcl complex are: two b 
cytochromes (b565 and b562), one c-type cyto- 
chrome (cl), one high potential iron-sulfur cluster 
(FeS) and a ubiquinone. 
Based on biochemical and biophysical investiga- 
tions of the electron transfer and proton translocation 
mechanisms, investigators in the field now generally 
favor the proton motive Q-cycle hypothesis [15,19]. 
The key feature of the Q-cycle hypothesis is the 
involvement of two separate binding sites for ubi- 
quinone and ubiquinol: Ubiquinol is first oxidized at 
the Qo site near the P side of the inner mitochondrial 
membrane, and ubiquinone is reduced at the Q~ site 
near the N side of the membrane. According to the 
Q-cycle model, one electron is transferred from 
ubiquinol to the Rieske iron-sulfur center, and then 
to cytochrome c via cytochrome cl. The newly 
generated reactive ubisemiquinone then reduces the 
low-potential cytochrome b566 beme (bL). Reduced 
bL rapidly transfers an electron to the high-potential 
cytochrome b562 heme (bH), which is located on the 
opposite side of the membrane. A ubiquinone or 
ubisemiquinone bound at the Qi site then oxidizes the 
reduced bH. Proton translocation is the result of 
deprotonation f ubiquinol at the Qo site and protona- 
tion of ubiquinol at the Qi site. 
In addition to the redox-active protein subunits, 
mitochondrial cytochrome bcl complex also contains 
non-redox active proteins, the so-called supernumeral 
subunits [20]. Since these supernumeral subunits are 
not present in bacterial cytochrome bcl complexes, 
their role in the complex has long been assumed to be 
structural rather than catalytic. Recent studies howed 
that plant mitochondrial bcl complexes from wheat, 
potato and spinach have mitochondrial processing 
peptidase (MPP) activity in addition to electron 
transfer activity [9]. MPP activity was associated 
with the core subunits [8,4,7,3] of the plant complex. 
However, a similar peptidase activity is not detected 
in the bovine bcl complex, even though the se- 
quences of core protein subunits 1 and 2 are highly 
homologous with the [3 and oL subunits of MPP [4], 
respectively. The crystal structure of bovine bcl has 
revealed a putative MPP active site and a zinc 
binding motif in the core subunits [22], which are 
associated with an unidentified polypeptide. When 
crystalline cytochrome bcl complex is treated with 
non-ionic detergents, such as Triton X-100 or 
zwitergen, the electron transfer activity is impaired 
and MPP activity is observed. Properties of the 
activated MPP were investigated [5]. 
In this paper we discuss the structural basis of the 
electron transfer eaction of beef heart mitochondrial 
cytochrome bcl complex based on the reported 3-D 
structural information [22] and new crystallographic 
observations made on this complex [11]. 
2. Cytochrome bcl complex functions as a dimer 
Most reports in the literature favor the dimeric 
association of the cytochrome bcl complex, even 
though isolation of monomeric omplex has been 
documented [17,16]. Crystallographic studies of the 
bcl complex not only show physical dimeric associa- 
tion (Fig. 1) but also suggest that the dimer is 
functional. The following structural evidences up- 
port the functional dimer hypothesis: First, since the 
distance of 21 /~ between two bL hemes in the two 
symmetry related monomers is the same as that 
between bL and bH hemes within a monomer, 
electron transfer between the two bL hemes of the 
dimer should be possible, especially when the mem- 
brane is highly energized. Second, the dimeric cyto- 
chrome bcl complex forms two symmetry related 
cavities in the membrane-spanning re ion. Although 
each monomer contains both Q~ and Qo sites, they 
cannot communicate with each other within a mono- 
mer. In the dimeric form of the bcl complex, each 
cavity connects the Qo site of one monomer to the Q~ 
site of the other, making it possible for a quinone 
molecule reduced at the Qi site of one monomer to be 
oxidized at the nearby Qo site of the other monomer 
without having to leave the bcl complex. This is 
consistent with the activity data showing that one 
mole of ubiquinone per mole of cl is sufficient for a 
maximal activity of electron transfer in the isolated 
succinate cytochrome c reductase [23]. Third, in the 
crystal structure, the head domain of the iron-sulfur 
protein (ISP) of one monomer interacts with cyto- 
chrome b of the other monomer (Fig. I). 















Fig. 1. Partial structure model of the dimeric bovine mitochondrial cytochrome bcl complex. The polypeptides are drawn as ribbons, and heme moieties 
and iron-sulfur cluster are drawn as the ball-and-stick model. The top of the diagram is in the mitochondrial inter-membrane space, and the bottom is in 
the mitochondrial matrix space. The molecule can be divided into three regions from the top to bottom: the inter-membrane space region, 
membrane-spanning re ion and the matrix region. The dimensions for each region of the molecule and the color code for each subunit are indicated. The 
unassigned peptide in between subunits core 1 and core 2 is most likely subunit 9. The diagram is produced with the program Setor. 
154 C. Yu et al. / Biochimica et Biophysica Acta 1365 (1998) 151-158 
3. Inhibitor binding and movement of iron- 
sulfur protein 
The binding sites for specific electron transfer 
inhibitors were determined by difference Fourier 
analysis between inhibitor-bound and native crystals. 
The relative locations for antimycin A, myxothiazol, 
5-undecyl-6-hydroxy-4,7-dioxobenzothiazole (UHD- 
BT), E-[3-methoxyacrylate-stilbene (MOAS) and 
stigmatellin are depicted in Fig. 2. These data show 
that the binding site of stigmatellin largely overlaps 
with that of UHDBT and only partly with that of 
myxothiazol, and the binding site of myxothiazol 
largely overlaps with that of MOAS, and only 
slightly overlaps with UHDBT. 
The relatively low electron density of the FeS 
center as compared to those of the bH and bL in the 
anomalous scattering difference maps have indicated 
that the ISP is somewhat mobile in the crystal [22]. 
Structural analyses of several inhibitor/bcl complex 
cocrystals uggest that the mobility of ISP is affected 
by the binding of Qo site inhibitors. Myxothiazol and 
MOAS enhance the mobility of ISP, whereas stig- 
matellin and UHDBT reduce the mobility of ISP in 
the crystal, as indicated by the enhancement of 
electron density of FeS (Fig. 3). 
complex used for crystallization contains sub-stoi- 
chiometric amounts of Q (-0.6 mole per mole of 
complex) [24]. How many Q molecules are bound to 
the Qo site is a question to be answered in the future. 
Binding of two Q per Qo site in bacterial cytochrome 
bcl complex has been indicated by EPR characteris- 
tics of the iron-sulfur cluster [6,2]. 
The observations that different Qo site inhibitors 
bind at slightly different locations in the Qo pocket 
and show different effects on ISP encourage us to 
speculate that there may be two Q binding sites 
within the Qo pocket, depending on its redox states, 
with the fully reduced form being closer to ISP (when 
FeS is in the oxidized state) and the half reduced 
form being closer to bL (when bL is in the oxidized 
state). In other words, the Q binding site closer to the 
ISP in the Qo pocket has higher binding affinity for 
fully reduced Q and the site closer to bL has higher 
binding affinity for ubisemiquinone. How cytochrome 
b senses such a shift in Q binding positions and 
subsequently releases ISP requires further structural 
investigation. 
5. Electron transfer rate and distances between 
the redox centers 
4. Ubiquinone binding sites 
The key feature of the Q-cycle mechanism is the 
involvement of two conceptually separated ubiquin- 
one/ubiquinol binding sites: one for ubiquinone 
reduction and one for ubiquinol oxidation. Structural 
analysis of the bci-inhibitor complexes reveals two 
separate inhibitor binding pockets, located at opposite 
sides of the membrane, for Qo and Qi site inhibitors. 
Binding of the Qi site inhibitor, antimycin, may cause 
dislocation of bound Q at the Qi site, as suggested by 
a negative lectron density in the difference Fourier 
map between inhibitor-bound and native crystals. 
Binding of the Qo site inhibitors, however, does not 
generate such a negative electron density in the 
difference maps, indicating that ubiquinone may not 
be bound in the Qo pocket in the native crystal. The 
failure to detect bound ubiquinone at the Qo pocket 
may be due to the low binding affinity of the Qo site 
for oxidized Q or to the fact that the cytochrome bcl 
The distances of 21 A between bL and bH and 27 
A between bL and FeS accommodate well the fast 
electron transfers observed between the two involved 
redox centers, assuming that ubiquinol is bound 
between bL and FeS. However, the distance of 31 /~ 
between heme cl and FeS, is difficult to explain in 
view of the large electron transfer ate between these 
two redox centers. One possible explanation is that 
movement of ISP may facilitate the observed fast 
electron transfer in this region in the following way: 
The iron-sulfur cluster (FeS) is reduced at a position 
27 /~ from bL and 31 A from cytochrome c l. Once 
reduced, it moves closer to cytochrome cl, to donate 
its electron. The iron-sulfur cluster reduced by the 
first electron of ubiquinol either cannot donate an 
electron to cytochrome c l before the second electron 
of ubiquinol is transferred to cytochrome bL, or the 
reoxidized ISP (after transfer of an electron to cl) 
cannot get back to cytochrome b to get re-reduced 
before the second electron being transferred to bL. It 
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is tempting to speculate that the change of the Q 
binding site and reduction of bL causes a conforma- 
tional change in cytochrome b that allows ISP to 
move close enough to heine c 1 to have fast electron 
transfer [13,21]. This model also would explain why 
ubisemiquinone, a more powerful reductant, reduces 
bL, but not FeS, during quinol oxidation. This 
speculation is in line with the observed effect of Qo 
site inhibitors binding on the mobility of ISP [11]. 
6. Electron transfer events at the Qo site 
One of the most important features of the Q cycle 
hypothesis i the bifurcation of electron transfer at the 
Qo site, the mechanism of which is still under 
intensive investigation. The information from crystal 
structure and from crystallographic inhibitor studies 
suggests two transient quinone binding sites in the 
inhibitor binding pocket at the Qo site: one Q binding 
site is likely to be where UHDBT binds, closer to ISP 
and designated as P1; the other Q binding site is 
where MOAS binds, closer to bL heme and desig- 
nated as P2. Analogous to inhibitor binding, binding 
of Q to P1 will cause ISP to be less mobile, and 
binding of Q to P2 will release ISP. Therefore, the 
electron transfer events at the Qo site can be de- 
scribed (Fig. 4) as follows: A ubiquinol molecule 
comes in, first binds to the P1 site, ISP is immobil- 
ized, one proton is released followed by transfer of 
one electron to ISR After the second proton is 
released, the ubisemiquinone radical moves from the 
P2 site, which causes the ISP to be released, and 
prevents the remaining electron from going to ISP. 
The second electron of quinol (ubisemiquinone) then 
reduces the bL heme. This completes the cycle in a 
manner similar to that in the proposed catalytic 
switch model [1]. This model requires that the P1 site 
has a higher affinity for ubiquinol when FeS is in the 
oxidized state, and that the P2 site has a higher 
affinity for ubisemiquinone when bL is in the oxi- 
dized state. The bifurcation of electron transfer at the 
Qo site is therefore realized by the large movement of 
the ISP. The movement is induced by the binding of 
different redox states of Q at two different subsites in 
the Qo binding pocket. The lack of detectable ubi- 
semiquinone radical at the Qo site, however, is 
inconsistent with this proposed electron transfer. 





Fig. 4. Schematic diagram of the electron transfer events at the Qo site. 
When bcl is in the oxidized form, the ISP prefers the position near 
cytochrome b and is slightly tumbling at that position. Once a ubiquinol 
molecule gets into the Qo pocket, it first occupies the PI site, fixing ISP 
in place, presumably by a conformational change in cytochrome b. The 
stabilization of ISP facilitates the transfer of the first electron from 
ubiquinol to ISP and releases two protons. The resulting ubisemiquinone 
is then switched to the second binding site, P2. This switch in position 
and the subsequent electron transfer from bL to bH heine may cause a 
conformational change in cytochrome b and, thus, result in the release of 
the reduced 1SP to a second position near cytochrome cl to deliver its 
electron. 
event at the Qo site is that the electron donor of FeS 
is the ubiquinol heme bL 3+ complex and not the 
ubiquinol alone. Once the first electron of ubiquinol 
in the complex transfers to FeS, the second electron 
immediately transfers to heine bL and then to heine 
bH and thus no semiubiquinone is generated. The 
electron transfer from heme bL to heme bH results in 
a conformational change of cytochrome b protein 
which makes (or allows) the reduced ISP to move to 
a position closer to heme cl to allow electron transfer 
to take place. Since the oxidation of the reduced FeS 
depends on the transfer of the second electron of 
ubiquinol from heme bL to heme bH, bifurcation is 
obligatory for the oxidation of ubiquinol in the bcl 
complex. 
7. Proton translocation: pumping/gating 
Although the Q cycle hypothesis explains well the 
2H+-electron stoichiometry of proton transfer and 
the structural information obtained so far generally 
158 C. Yu et al. / Biochimica et Biophysica Acta 1365 (1998) 151-158 
supports this hypothesis, the proton transfer path in 
the bcl molecule during ubiquinol oxidation is still 
not clear. No obvious proton channel was found in 
the cytochrome bcl complex at the current level of 
structure resolution. This, of course, does not exclude 
the participation of bound water in proton movement. 
Since the simplest bacterial bcl complex has no 
supernumeral subunits and has full proton transloca- 
tion ability, proton translocation must be achieved 
through transmembrane helices of cytochrome b, cl 
and ISE Van der Waals surface of the matrix side of 
these transmembrane helices, particularly in cyto- 
chrome b, shows several openings for proton uptake 
from the matrix. Since the Van der Waals surface of 
the cytoplasmic side is totally sealed, proton exit 
must be accompanied by some sort of conformational 
change or gating device. The available biochemical 
data indicate that the iron-sulfur cluster of ISP may 
play an essential role in proton exit. It was reported 
that the FeS of ISP in the bcl complex can be 
destroyed by the destruction of one of the histidine 
ligands during illumination of the hematoporphyrin- 
treated complex ([14]). The resulting complex leaks 
protons when reconstituted into phospholipid vesi- 
cles. A strong redox state-dependent pK a of the 
histidyl ligands of FeS cluster also suggests that they 
may be involved in proton release [12]. Cytochrome 
bcl complex depleted in iron-sulfur protein, pre- 
pared by biochemical methods or by genetic manipu- 
lation, forms proton leaking vesicles when embedded 
in phospholipid vesicles. These results also support 
the above speculation. 
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